Adagio Medical Holdings, Inc.
ADGM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -10.3% | 58.7% | -30% | – |
| Cost of Goods Sold | $2 | $1 | $1 | $1 |
| Gross Profit | -$2 | -$1 | -$1 | -$1 |
| % Margin | -620.1% | -335.3% | -363% | -328.9% |
| R&D Expenses | $5 | $15 | $18 | $15 |
| G&A Expenses | $0 | $5 | $0 | $0 |
| SG&A Expenses | $7 | $12 | $5 | $4 |
| Sales & Mktg Exp. | $0 | $7 | $0 | $0 |
| Other Operating Expenses | $49 | $0 | $0 | $0 |
| Operating Expenses | $61 | $27 | $23 | $20 |
| Operating Income | -$62 | -$28 | -$24 | -$21 |
| % Margin | -23,226.8% | -9,314% | -12,652.4% | -7,646.3% |
| Other Income/Exp. Net | $9 | -$10 | $0 | $1 |
| Pre-Tax Income | -$54 | -$38 | -$24 | -$20 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$54 | -$38 | -$24 | -$20 |
| % Margin | -19,986.2% | -12,715.3% | -12,525.4% | -7,384.4% |
| EPS | -3.54 | -4.86 | 0.056 | -0.34 |
| % Growth | 27.2% | -8,841% | 116.4% | – |
| EPS Diluted | -3.54 | -4.86 | 0.056 | -0.34 |
| Weighted Avg Shares Out | 15 | 8 | 19 | 19 |
| Weighted Avg Shares Out Dil | 15 | 8 | 19 | 19 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | -$1 | $2 | $0 | $0 |
| Depreciation & Amortization | -$8 | $1 | $0 | $0 |
| EBITDA | -$62 | -$27 | -$23 | -$20 |
| % Margin | -23,226.8% | -9,136.7% | -12,191% | -7,260% |